Literature DB >> 25970282

Putamina involvement in Wernicke encephalopathy induced by Janus Kinase 2 inhibitor.

Jorge Rodríguez-Pardo1, Inmaculada Puertas-Muñoz, Patricia Martínez-Sánchez, Javier Díaz de Terán, Irene Pulido-Valdeolivas, Blanca Fuentes.   

Abstract

OBJECTIVE: The aim of the study was to report a case of Wernicke encephalopathy (WE) due to fedratinib (Janus Kinase 2 inhibitor) treatment with atypical neuroimaging findings.
METHODS: We present a detailed report of the case and literature review.
RESULTS: A 68-year-old woman under treatment with fedratinib (investigational JAK2 inhibitor) developed memory impairment, diplopia, and ataxia compatible with WE. Brain magnetic resonance imaging showed extensive lesions involving medial thalami, periaqueductal gray, caudate nuclei, and putamina. Thiamine supplementation provided clinical recovery and radiological improvement of the lesions described. Basal ganglia lesions have been previously described in children with this disease, but this is rarely found in adults. Clinical trials including fedratinib have been recently discontinued, and its involvement in pathogenesis of WE may be related to thiamine-transporter inhibition.
CONCLUSIONS: Our case represents an example of drug-related WE, with a rare radiological pattern. Precocious diagnosis and treatment are essential to prevent irreversible brain injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25970282     DOI: 10.1097/WNF.0000000000000083

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  3 in total

1.  Wernicke encephalopathy in a patient with liver failure: Clinical case report.

Authors:  Pan Zhao; Yanling Zhao; Zhenman Wei; Jing Chen; Lilong Yan
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

2.  A patient with Korsakoff syndrome of psychiatric and alcoholic etiology presenting as DSM-5 mild neurocognitive disorder.

Authors:  Georgios Nikolakaros; Timo Kurki; Arttu Myllymäki; Tuula Ilonen
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-22       Impact factor: 2.570

Review 3.  On the dynamic and even reversible nature of Leigh syndrome: Lessons from human imaging and mouse models.

Authors:  Melissa A Walker; Maria Miranda; Amanda Allred; Vamsi K Mootha
Journal:  Curr Opin Neurobiol       Date:  2021-10-14       Impact factor: 7.070

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.